RxDoctor Payments Data

Ashvin Patel, MD

Orthopaedic Surgery of the Spine · Sarasota, FLNPI 1215975172

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Centinel Spine, LLC at 39.9% of the total. 2025 is the largest year on record at $25,702, 3.2 times the $7,987 reported in 2019.

$78,889in general payments, 2019–2025

Across 162 payments — averaging $486.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Centinel Spine, LLC$32K
  • Carlsmed, Inc.$31K
  • Globus Medical$11K
  • Johnson & Johnson$2K
  • Medical Device Business Services, Inc.$1K
  • Highridge Medical LLC$1K
  • plus $1K from 13 others
$982,068in research payments, 2019–2025

Across 122 payments — averaging $8049.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Centinel Spine, LLC$545K
  • Carlsmed, Inc.$271K
  • Globus Medical$118K
  • Premia Spine, Ltd.$32K
  • Medtronic$15K
  • Surgalign Spine Technologies, Inc.$2K

What the payments were for

  • Consulting fees$46,97560%
  • Speaking & faculty fees$9,35012%
  • Travel & lodging$16,04420%
  • Food & beverage$6,2718%
  • Education$2120%
  • Other$370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,889 in reported general payments places this provider in the 65th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$779,622
Medicare patients
1,112
Services billed
4,606

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen138$1,690
Celecoxib48$1,677
Oxycodone Hcl251$1,654
Methylprednisolone177$1,154
Pregabalin36$870
Gabapentin68$863
Ondansetron Hcl79$441
Tramadol Hcl109$384
Meloxicam113$256
Cyclobenzaprine Hcl24$98
Folic Acid13$55
Lorazepam23$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →